702 filings
Page 6 of 36
8-K
fy2zg2z7b4nbdf3ch9u3
9 Nov 21
Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
4:02pm
8-K
st20l1pp
21 Sep 21
Termination of a Material Definitive Agreement
7:51am
8-K
g1co bxmtk
9 Sep 21
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
8:20am
8-K
1h3nszqlg09 y753hrz
23 Aug 21
Departure of Directors or Certain Officers
4:50pm
8-K
ivm oh6mr
5 Aug 21
Acorda Therapeutics Reports Second Quarter 2021 Financial Results
4:03pm
8-K
tx7qdo9qn 2ecg
23 Jul 21
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
9:17am
8-K
989y7
16 Jun 21
Acorda Therapeutics Announces Repayment of Convertible Senior Notes
8:55am
8-K
ee7ka4iqb3qhj
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
cfh7p1c1a1zr6h2q11s
2 Jun 21
Other Events
6:20am
DEFA14A
g5i3b242fc3b
21 May 21
Additional proxy soliciting materials
4:01pm
DEFA14A
yltt0foe4rg6s0g2izzh
14 May 21
Additional proxy soliciting materials
4:03pm
8-K
3nooq1z7lq589gr
6 May 21
Acorda Therapeutics Reports First Quarter 2021 Financial Results
4:02pm
8-K
argygpa3y 6kel25swe
4 Mar 21
Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:02pm
8-K
hak0n7nmqze3lyrthquj
19 Feb 21
Acorda Therapeutics Announces Departure of
7:03am
8-K
r8x mc51qi5wp8kx
17 Feb 21
Acorda Therapeutics Announces Completion of Sale of Manufacturing Operations to Catalent
7:50am
8-K
uea5d9jg7sr2x9es08
20 Jan 21
Other Events
4:06pm